2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm: Expansion of Anti-HLA Antibodies After Renal Transplantation and Prognosis in Those Which Fix C1q.

P. Ruiz-Esteban,¹ M. Gonzalez-Molina,¹ A. Caballero,² A. Torio,² M. Leon,³ E. Palma,¹ D. Burgos,¹ M. Cabello,¹ V. Lopez,¹ M. Rodriguez,⁴ D. Hernandez.¹

Poster Session D: Antibody Mediated Rejection: Session #2 • Halls C&D

6:00pm-7:00pm: Experience of Short-Term Preemptive Treatment for Cytomegalovirus Infection in Seropositive Patients After Liver Transplantation – Ten Years Result of a Single Institution.

T.-J. Wu, Y.-C. Wang, C.-H. Cheng, T.-H. Wu, R.-S. Soong, C.-F. Lee, H.-S. Chou, K.-M. Chan, W.-C. Lee.

Poster Session D: Liver: Immunosuppression and Rejection • Halls C&D

6:00pm-7:00pm: Factors Associated with Response to Plasmapheresis in Patients with Recurrent FSGS.

J. Shoji,¹ V. Tatapudi,² Z. Laszik,¹ A. Jones,³ J. Wolf,⁴ D. Adey,¹ F. Vincenti.¹

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Factors in a Successful Transfer of Pediatric Liver Transplant Recipients to Adult-Based Care.

J. Bilhartz, M. Lopez, J. Magee, V. Shieck, S. Eder, E. Fredericks.

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Factors Mediating Kidney Rejection in Patients of Simultaneous Liver-Kidney Transplants.

R. Dong, A. Tambur, L. Gallon, J. Levitsky.

Poster Session D: Antibody Mediated Rejection: Session #2 • Halls C&D

6:00pm-7:00pm: Factors Predicting Risk for Antibody-Mediated Rejection in Highly Sensitized Pediatric Renal Transplants.

I. Kim,¹ J. Choi,¹ A. Vo,¹ S. Louie,¹ J. Mirocha,² S. Jordan,¹ E. Kamil,¹ D. Puliyanda.¹

Poster Session D: Kidney-Pediatrics • Halls C&D

6:00pm-7:00pm: FGF and Wnt Signaling in Pancreatic Progenitor and Beta-Cell Growth.

S. Afelik,¹ N. Yonan,¹ B. Pool,² J. Jensen,² J. Oberholzer.¹

Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection • Halls C&D

6:00pm-7:00pm: First Experience with Obinutuzumab (Type II Anti-CD20) in Patients with Treatment-Resistant Glomerular Diseases and Antibody-Mediated Rejection.

J. Choi, S. Jordan, A. Vo.

Poster Session D: Kidney Immunosuppression: Novel Agents • Halls C&D

6:00pm-7:00pm: Focal C4d Staining in Biopsies of Kidney Transplant Recipients Is Not Associated with Antibody Mediated Rejection and Does Not Correlate with Graft Survival.

R. Prashar, M. Goggins, L. Yessayan, A. Patel, M. Goggins.

Poster Session D: Antibody Mediated Rejection: Session #2 • Halls C&D

6:00pm-7:00pm: Genetic TIM-4 Deletion Promotes Immunoregulatory Tissue-Resident Macrophage Survival and Lowers the Barrier to Cardiac Allograft Tolerance.

T. Thornley,¹ P. Kyriazis,¹ K. Agarwal,¹ Z. Fang,¹ L. Ma,¹ V. Chipashvili,¹ M. Koulmanda,^1,2 T. Strom.^1,2

Poster Session D: Late Breaking • Halls C&D